ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+5.02%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$431M
AUM Growth
+$431M
(+20%)
Cap. Flow
+$69.5M
Cap. Flow
% of AUM
16.11%
Top 10 Holdings %
Top 10 Hldgs %
23.13%
Holding
178
New
54
Increased
29
Reduced
24
Closed
43
Top Buys
| 1 |
POL.WS
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
|
$14.7M |
| 2 |
Xtant Medical Holdings
XTNT
|
$13.5M |
| 3 |
KLR
Kaleyra, Inc.
KLR
|
$7.83M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$7.72M |
| 5 |
Palisade Bio
PALI
|
$7.43M |
Top Sells
| 1 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
$8.32M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
$5.67M |
| 3 |
Sutro Biopharma
STRO
|
$5.16M |
| 4 |
MBTCU
Nocturne Acquisition Corporation Unit
MBTCU
|
$5M |
| 5 |
Imunon
IMNN
|
$4.83M |
Sector Composition
| 1 | Healthcare | 85.11% |
| 2 | Financials | 3.37% |
| 3 | Technology | 1.96% |
| 4 | Consumer Discretionary | 0.54% |
| 5 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
POL.WS
1
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
| $14.7M | 3.42% | +6,886,600 | New | +$14.7M |
|
|
2
Xtant Medical Holdings
XTNT
$83.3M
| $13.5M | 3.14% | +8,292,602 | New | +$13.5M |
|
3
Protagonist Therapeutics
PTGX
$3.67B
| $12.7M | 2.94% | 282,445 +44,091 | +18% | +$1.98M |
|
4
Crinetics Pharmaceuticals
CRNX
$2.92B
| $10M | 2.33% | 533,033 +171,103 | +47% | +$3.23M |
|
5
Aldeyra Therapeutics
ALDX
$351M
| $9.79M | 2.27% | 864,020 +315,795 | +58% | +$3.58M |
|
|
CTIC
6
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $9.2M | 2.13% | 3,678,677 +3,089,685 | +525% | +$7.72M |
|
|
KLR
7
DELISTED
Kaleyra, Inc.
KLR
| $7.83M | 1.82% | +640,000 | New | +$7.83M |
|
|
RCOR
8
DELISTED
Renovacor, Inc.
RCOR
| $7.51M | 1.74% | 753,874 +500 | +0.1% | +$4.98K |
|
|
9
Palisade Bio
PALI
$6.3M
| $7.43M | 1.72% | +1,824,894 | New | +$7.43M |
|
10
Verastem
VSTM
$569M
| $6.98M | 1.62% | 1,715,589 -857,633 | -33% | -$3.49M |
|
11
Curis
CRIS
$20.9M
| $6.69M | 1.55% | 829,000 +56,991 | +7% | +$460K |
|
12
Lantheus
LNTH
$3.73B
| $6.64M | 1.54% | 240,066 -35,000 | -13% | -$967K |
|
13
Arcutis Biotherapeutics
ARQT
$1.86B
| $6.31M | 1.46% | 231,314 +117,352 | +103% | +$3.2M |
|
14
ESSA Pharma
EPIX
$11.4M
| $6.1M | 1.41% | 213,528 -16,535 | -7% | -$472K |
|
15
electroCore
ECOR
$40.3M
| $5.95M | 1.38% | +5,000,000 | New | +$5.95M |
|
16
Verrica Pharmaceuticals
VRCA
$52.8M
| $5.93M | 1.38% | 525,127 -37,827 | -7% | -$427K |
|
|
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $5.88M | 1.36% | 416,567 +210,768 | +102% | +$2.98M |
|
|
SYRS
18
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.87M | 1.36% | 1,076,942 +950,240 | +750% | +$5.18M |
|
19
CareDx
CDNA
$727M
| $5.81M | 1.35% | 63,434 -17,850 | -22% | -$1.63M |
|
20
Insmed
INSM
$28.8B
| $5.79M | 1.34% | 203,354 +93,100 | +84% | +$2.65M |
|
|
ISEE
21
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.7M | 1.32% | 902,633 | – | – |
|
|
BLU
22
DELISTED
BELLUS Health Inc.
BLU
| $5.56M | 1.29% | 1,788,789 +215,400 | +14% | +$670K |
|
23
Globus Medical
GMED
$8.27B
| $5.49M | 1.27% | 70,833 +21,971 | +45% | +$1.7M |
|
24
CytomX Therapeutics
CTMX
$336M
| $5.46M | 1.27% | 862,417 +379,376 | +79% | +$2.4M |
|
25
Myriad Genetics
MYGN
$593M
| $5.24M | 1.21% | 171,242 -543 | -0.3% | -$16.6K |
|